Abstract
While routine visits after intrauterine device (IUD) insertion are not recommended for adolescents and young adults by evidence-based guidelines, they can present valuable opportunities to answer patient questions, review method-specific information, and offer routine reproductive health care. It is important for providers to be aware of the range of bleeding and cramping that happens after IUD placement, both by timing and type of device. This knowledge helps clinicians provide reassurance, as well as understand the treatment options available for those whose symptoms are bothersome. Understanding additional IUD-related symptoms and how to provide counseling in a patient-centered manner can help to maintain the ongoing patient-clinician relationship and improve method satisfaction. This chapter will review the rationale for scheduled versus problem-based visits after IUD insertion, describe the common and less common patient concerns after IUD insertion, and provide information to help clinicians manage IUD concerns. Lastly, we will discuss how to integrate a reproductive justice framework into discussions around IUD removal.
Keywords
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AYA:
-
Adolescent and Young Adult
- BV:
-
Bacterial Vaginosis
- CDC:
-
Centers for Disease Control
- IUD:
-
Intrauterine Device
- LNG:
-
Levonorgestrel
- NSAIDs:
-
Nonsteroidal Anti-inflammatory drugs
- STI:
-
Sexually Transmitted Infection
References
Curtis KM, Jatlaoui TC, Tepper NK, Zapata LB, Horton LG, Jamieson DJ, et al. U.S. selected practice recommendations for contraceptive use, 2016. MMWR Recomm Rep. 2016;65:1–66.
Steenland MW, Zapata LB, Brahmi D, Marchbanks PA, Curtis KM. The effect of follow-up visits or contacts after contraceptive initiation on method continuation and correct use. Contraception. 2013;87:625–30.
Herceg-Baron R, Furstenberg FF Jr, Shea J, Harris KM. Supporting teenagers’ use of contraceptives: a comparison of clinic services. Fam Plan Perspect. 1986;18:61–6.
Kirby D, Raine T, Thrush G, Yuen C, Sokoloff A, Potter SC. Impact of an intervention to improve contraceptive use through follow-up phone calls to female adolescent clinic patients. Perspect Sex Reprod Health. 2010;42:251–7.
Neuteboom K, de Kroon CD, Dersjant-Roorda M, Jansen FW. Follow-up visits after IUD-insertion: sense or nonsense? A technology assessment study to analyze the effectiveness of follow-up visits after IUD insertion. Contraception. 2003;68:101–4.
Bernard A, Satterwhite CL, Reddy M. Frequency of 6-week follow-up appointment scheduling after intrauterine device insertion. BMJ Sex Reprod Health. 2018;44:33–6.
Draper IB, Haque MS, McManus RJ. Routine intrauterine device checks: are they advisable? J Fam Plann Reprod Health Care. 2012;38:15–8.
Hameed W, Azmat SK, Ali M, Ishaque M, Abbas G, Munroe E, et al. Comparing effectiveness of active and passive client follow-up approaches in sustaining the continued use of Long Acting Reversible Contraceptives (LARC) in rural Punjab: a multicentre, non-inferiority trial. PLoS One. 2016;11:e0160683.
L’Engle KL, Mangone ER, Parcesepe AM, Agarwal S, Ippoliti NB. Mobile phone interventions for adolescent sexual and reproductive health: a systematic review. Pediatrics 2016;138. https://doi.org/10.1542/peds.2016-0884.
Chernick LS, Stockwell MS, Wu M, Castaño PM, Schnall R, Westhoff CL, et al. Texting to increase contraceptive initiation among adolescents in the emergency department. J Adolesc Health. 2017;61:786–90.
Haider S, Dodge LE, Brown BA, Hacker MR, Raine TR. Evaluation of e-mail contact to conduct follow-up among adolescent women participating in a longitudinal cohort study of contraceptive use. Contraception. 2013;88:18–23.
Alnakash AH. Influence of IUD perceptions on method discontinuation. Contraception. 2008;78:290–3.
Brown MK, Auerswald C, Eyre SL, Deardorff J, Dehlendorf C. Identifying counseling needs of nulliparous adolescent intrauterine contraceptive users: a qualitative approach. J Adolesc Health. 2013;52:293–300.
Dehlendorf C, Krajewski C, Borrero S. Contraceptive counseling: best practices to ensure quality communication and enable effective contraceptive use. Clin Obstet Gynecol. 2014;57:659–73.
Schivone GB, Glish LL. Contraceptive counseling for continuation and satisfaction. Curr Opin Obstet Gynecol. 2017;29:443–8.
Ylikorkala O, Kauppila A, Siljander M. Anti-prostglandin therapy in prevention of side-effects of intrauterine contraceptive devices. Lancet. 1978;2:393–5.
Diedrich JT, Desai S, Zhao Q, Secura G, Madden T, Peipert JF. Association of short-term bleeding and cramping patterns with long-acting reversible contraceptive method satisfaction. Am J Obstet Gynecol. 2015;212:50.e1–8.
Fraser IS, Critchley HOD, Broder M, Munro MG. The FIGO recommendations on terminologies and definitions for normal and abnormal uterine bleeding. Semin Reprod Med. 2011;29:383–90.
Suvisaari J, Lähteenmäki P. Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine system. Contraception. 1996;54:201–8.
Ylikorkala O. Prostaglandin synthesis inhibitors in menorrhagia, intrauterine contraceptive device-induced side effects and endometriosis. Pharmacol Toxicol. 1994;75(Suppl 2):86–8.
Hubacher D, Chen P-L, Park S. Side effects from the copper IUD: do they decrease over time? Contraception. 2009;79:356–62.
Sanders JN, Adkins DE, Kaur S, Storck K, Gawron LM, Turok DK. Bleeding, cramping, and satisfaction among new copper IUD users: a prospective study. PLoS One. 2018;13:e0199724.
Hubacher D, Reyes V, Lillo S, Pierre-Louis B, Zepeda A, Chen P-L, et al. Preventing copper intrauterine device removals due to side effects among first-time users: randomized trial to study the effect of prophylactic ibuprofen. Hum Reprod. 2006;21:1467–72.
Grimes DA, Hubacher D, Lopez LM, Schulz KF. Non-steroidal anti-inflammatory drugs for heavy bleeding or pain associated with intrauterine-device use. Cochrane Database Syst Rev. 2006:CD006034.
Nelson AL. LNG-IUS 12: a 19.5 levonorgestrel-releasing intrauterine system for prevention of pregnancy for up to five years. Expert Opin Drug Deliv. 2017;14:1131–40.
Mejia M, McNicholas C, Madden T, Peipert JF. Association of baseline bleeding pattern on amenorrhea with levonorgestrel intrauterine system use. Contraception. 2016;94:556–60.
Skyla (levonorgestrel-releasing intrauterine system). Highlights of prescribing information [Internet]. [cited 17 Dec 2018]. Available: http://labeling.bayerhealthcare.com/html/products/pi/Skyla_PI.pdf.
Mansour D, Inki P, Gemzell-Danielsson K. Efficacy of contraceptive methods: a review of the literature. Eur J Contracept Reprod Health Care. 2010;15(Suppl 2):S19–31.
Godfrey EM, Folger SG, Jeng G, Jamieson DJ, Curtis KM. Treatment of bleeding irregularities in women with copper-containing IUDs: a systematic review. Contraception. 2013;87:549–66.
Friedlander E, Kaneshiro B. Therapeutic options for unscheduled bleeding associated with long-acting reversible contraception. Obstet Gynecol Clin N Am. 2015;42:593–603.
Abdel-Aleem H, d’Arcangues C, Vogelsong KM, Gaffield ML, Gülmezoglu AM. Treatment of vaginal bleeding irregularities induced by progestin only contraceptives. Cochrane Database Syst Rev. 2013:CD003449.
Zigler RE, McNicholas C. Unscheduled vaginal bleeding with progestin-only contraceptive use. Am J Obstet Gynecol. 2017;216:443–50.
Simmons KB, Edelman AB, Fu R, Jensen JT. Tamoxifen for the treatment of breakthrough bleeding with the etonogestrel implant: a randomized controlled trial. Contraception. 2017;95:198–204.
Ylikorkala O, Viinikka L. Comparison between antifibrinolytic and antiprostaglandin treatment in the reduction of increased menstrual blood loss in women with intrauterine contraceptive devices. Br J Obstet Gynaecol. 1983;90:78–83.
Guiahi M, McBride M, Sheeder J, Teal S. Short-term treatment of bothersome bleeding for etonogestrel implant users using a 14-day oral contraceptive pill regimen: a randomized controlled trial. Obstet Gynecol. 2015;126:508–13.
Hou MY, McNicholas C, Creinin MD. Combined oral contraceptive treatment for bleeding complaints with the etonogestrel contraceptive implant: a randomised controlled trial. Eur J Contracept Reprod Health Care. 2016;21:361–6.
Akers AY, Steinway C, Sonalkar S, Perriera LK, Schreiber C, Harding J, et al. Reducing pain during intrauterine device insertion: a randomized controlled trial in adolescents and young women. Obstet Gynecol. 2017;130:795–802.
Ngo LL, Braaten KP, Eichen E, Fortin J, Maurer R, Goldberg AB. Naproxen sodium for pain control with intrauterine device insertion: a randomized controlled trial. Obstet Gynecol. 2016;128:1306–13.
Rapkin RB, Achilles SL, Schwarz EB, Meyn L, Cremer M, Boraas CM, et al. Self-administered lidocaine gel for intrauterine device insertion in nulliparous women: a randomized controlled trial. Obstet Gynecol. 2016;128:621–8.
Imai A, Matsunami K, Takagi H, Ichigo S. Levonorgestrel-releasing intrauterine device used for dysmenorrhea: five-year literature review. Clin Exp Obstet Gynecol. 2014;41:495–8.
Golightly E, Gebbie AE. Low-lying or malpositioned intrauterine devices and systems. J Fam Plann Reprod Health Care. 2014;40:108–12.
Rhudy JL, Meagher MW. Fear and anxiety: divergent effects on human pain thresholds. Pain. 2000;84:65–75.
Jatlaoui TC, Riley HEM, Curtis KM. The safety of intrauterine devices among young women: a systematic review. Contraception. 2017;95:17–39.
Dickerson LM, Diaz VA, Jordon J, Davis E, Chirina S, Goddard JA, et al. Satisfaction, early removal, and side effects associated with long-acting reversible contraception. Fam Med. 2013;45:701–7.
Maguire K, Joslin-Roher S, Westhoff CL, Davis AR. IUDs at 1 year: predictors of early discontinuation. Contraception. 2015;92:575–7.
Davies A, Fleming C. Do intrauterine device/intrauterine system users check their threads? J Fam Plann Reprod Health Care. 2014;40:122–5.
Apter D, Gemzell-Danielsson K, Hauck B, Rosen K, Zurth C. Pharmacokinetics of two low-dose levonorgestrel-releasing intrauterine systems and effects on ovulation rate and cervical function: pooled analyses of phase II and III studies. Fertil Steril. 2014;101:1656–62.e1–4.
Mirena (levonorgestrel-releasing intrauterine system). Highlights of prescribing information [Internet]. [cited 13 Jan 2019]. Available: https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021225s027lbl.pdf.
Raifman S, Barar R, Foster D. Effect of knowledge of self-removability of intrauterine contraceptives on uptake, continuation, and satisfaction. Womens Health Issues. 2018;28:68–74.
Lopez LM, Ramesh S, Chen M, Edelman A, Otterness C, Trussell J, et al. Progestin-only contraceptives: effects on weight. Cochrane Database Syst Rev. 2016:CD008815.
Silva Dos Santos PN, Madden T, Omvig K, Peipert JF. Changes in body composition in women using long-acting reversible contraception. Contraception. 2017;95:382–9.
Achilles SL, Austin MN, Meyn LA, Mhlanga F, Chirenje ZM, Hillier SL. Impact of contraceptive initiation on vaginal microbiota. Am J Obstet Gynecol. 2018;218:622.e1–622.e10.
Madden T, Grentzer JM, Secura GM, Allsworth JE, Peipert JF. Risk of bacterial vaginosis in users of the intrauterine device: a longitudinal study. Sex Transm Dis. 2012;39:217–22.
Stoddard AM, Xu H, Madden T, Allsworth JE, Peipert JF. Fertility after intrauterine device removal: a pilot study. Eur J Contracept Reprod Health Care. 2015;20:223–30.
Girum T, Wasie A. Return of fertility after discontinuation of contraception: a systematic review and meta-analysis. Contracept Reprod Med. 2018;3:9.
Higgins JA. Celebration meets caution: LARC’s boons, potential busts, and the benefits of a reproductive justice approach. Contraception. 2014;89:237–41.
Faundes A, Segal SJ, Adejuwon CA, Brache V, Leon P, Alvarez-Sanchez F. The menstrual cycle in women using an intrauterine device. Fertil Steril. 1980;34:427–30.
Nielsen D, Christensen OM, Nielsen R, Larsen J. Unwanted pregnancy after removal of the IUD. Ugeskr Laeger. 1990;152:3172–3.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Coles, M.S. (2019). Follow-Up After IUD Insertions: Managing IUD Expectations, Addressing Side Effects, and Providing Post-Insertion Counseling. In: Coles, M., Mays, A. (eds) Optimizing IUD Delivery for Adolescents and Young Adults. Springer, Cham. https://doi.org/10.1007/978-3-030-17816-1_11
Download citation
DOI: https://doi.org/10.1007/978-3-030-17816-1_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-17815-4
Online ISBN: 978-3-030-17816-1
eBook Packages: MedicineMedicine (R0)